Zimmer Biomet Holdings Inc (NYSE:ZBH) Sellers Strengthened Their Shorts By 4.87%

June 29, 2018 - By Norman Soto

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Corporate Logo

Zimmer Biomet Holdings Inc (NYSE:ZBH) had an increase of its short interest by 4.87%. FINRA announced in June ZBH’s total 3.56 million short interest. That’s 4.87% up from 3.40 million shares. Zimmer Biomet Holdings Inc (NYSE:ZBH) has 1.58M shares average volume. It’ll cost 2 days for ZBH to restore its former position. Float short on Zimmer Biomet Holdings Inc is 1.76%.

Ticker’s shares touched $112.92 during the last trading session after 1.48% change.Zimmer Biomet Holdings, Inc. has volume of 268,906 shares. Since June 29, 2017 ZBH has declined 6.89% and is downtrending. The stock underperformed the S&P500 by 19.46%.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.The firm is worth $22.95 billion. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental.The P/E ratio is 13.65. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Ratings Coverage

Total analysts of 17 have positions in Zimmer Biomet Holdings (NYSE:ZBH) as follows: 11 rated it a “Buy”, 1 with “Sell” and 5 with “Hold”. The positive are 65%. Since January 4, 2018 according to StockzIntelligence Inc Zimmer Biomet Holdings has 22 analyst reports. On Friday, April 27 the stock has “Overweight” rating by Morgan Stanley. On Thursday, April 26 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Hold” rating given by Canaccord Genuity. On Tuesday, April 24 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) earned “Buy” rating by Guggenheim. In Friday, April 27 report JMP Securities maintained it with “Market Outperform” rating and $133 target. The company rating was downgraded by Argus Research on Friday, June 22. On Thursday, January 4 the firm has “Hold” rating by Canaccord Genuity given. On Tuesday, January 30 the firm has “Buy” rating by Jefferies given. The company rating was maintained by Leerink Swann on Wednesday, January 31. On Friday, March 23 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Neutral” rating given by Robert W. Baird. On Wednesday, January 31 Guggenheim maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) with “Buy” rating.

A couple more Zimmer Biomet Holdings, Inc. (NYSE:ZBH) news were published by: Seekingalpha.com which released on June 27, 2018 “Medical device makers ISRG, BSX, ABT started with bullish view at Bernstein”, also Benzinga.com on June 24, 2018 published “Benzinga’s Bulls & Bears Of The Week: AMD, Disney, Nike, Tesla And More”, the next Benzinga.com is “Benzinga’s Top Upgrades, Downgrades For June 22, 2018” on June 22, 2018. Benzinga.com has article titled “Argus Drops Bullish Zimmer Biomet Thesis On Manufacturing, Supply, Sales Worries”.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.